Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2019

May 07, 2019

SELL
$1.83 - $2.38 $23,332 - $30,345
-12,750 Closed
0 $0
Q4 2018

Feb 08, 2019

SELL
$1.98 - $3.01 $6,534 - $9,933
-3,300 Reduced 20.56%
12,750 $25,000
Q3 2018

Nov 02, 2018

SELL
$2.6 - $3.14 $13,000 - $15,700
-5,000 Reduced 23.75%
16,050 $50,000
Q2 2018

Aug 14, 2018

SELL
$2.84 - $3.29 $24,850 - $28,787
-8,750 Reduced 29.36%
21,050 $60,000
Q1 2018

May 10, 2018

SELL
$3.15 - $4.16 $3,780 - $4,992
-1,200 Reduced 3.87%
29,800 $95,000
Q4 2017

Feb 12, 2018

SELL
$3.07 - $4.68 $14,045 - $21,411
-4,575 Reduced 12.86%
31,000 $95,000
Q2 2017

Aug 09, 2017

BUY
N/A
35,575
35,575 $180,000

Others Institutions Holding EVGN

About Evogene Ltd.


  • Ticker EVGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 41,202,000
  • Market Cap $26.8M
  • Description
  • Evogene Ltd., together with its subsidiaries, operates as a computational biology company. It focuses on product discovery and development in multiple life-science based industries, including human health and agriculture, through the use of its Computational Predictive Biology (CPB) platform. The CPB platform, incorporating a deep understanding ...
More about EVGN
Track This Portfolio

Track Stockman Wealth Management, Inc. Portfolio

Follow Stockman Wealth Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Stockman Wealth Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Stockman Wealth Management, Inc. with notifications on news.